Mammary gland carcinoma in a dog with peripheral blood and bone marrow involvement associated with disseminated intravascular coagulation

Veterinary Clinical Pathology

Volumn 41, Issue 2, 2012, Pages 261-265

  Jaillardon, Laetitia ^a   Barthélemy, Anthony ^b   Goy Thollot, Isabelle ^b   Pouzot Nevoret, Céline ^b   Fournel Fleury, Corinne ^b  

^a Laboratoire d'Acoustique Environnementale   (France)

^b VETAGRO SUP   (France)

Author keywords

Buffy coat; Circulating tumor cells; Cytokeratin; Solid tumor

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CELL COUNT; BONE MARROW CANCER; CARCINOMA; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; METASTASIS; PATHOLOGY;

ANIMALS; BLOOD CELL COUNT; BONE MARROW NEOPLASMS; CARCINOMA; DISSEMINATED INTRAVASCULAR COAGULATION; DOG DISEASES; DOGS; FEMALE; MAMMARY NEOPLASMS, ANIMAL;

CANIS FAMILIARIS;

EID: 84861774617     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2012.00433.x     Document Type: Article

References (24)

1. Höinghaus R, Hewicker-Trautwein M, Mischke R. Immunocytochemical differentiation of neoplastic and hyperplastic canine epithelial lesions in cytologic imprint preparations. Vet J. 2007;173:79-90.
2. Marconato L, Bettini G, Giacoboni C, et al. Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement. J Vet Med Intern. 2008;22:1001-1007.
3. Rossi S, Gelain ME, Comazzi S. Disseminated histiocytic sarcoma with peripheral blood involvement in a Bernese Mountain dog. Vet Clin Pathol. 2009;38:126-130.
4. Albanese F, Salerni FL, Giordano S, Marconato L. Extragenital transmissible venereal tumour associated with circulating neoplastic cells in an immunologically compromised dog. Vet Comp Oncol. 2006;4:57-62.
5. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329-340.
6. Riethdorf S, Wikman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer. 2008;123:1991-2006.
7. Riethdorf S, Pantel K. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology. 2008;75:140-148.
8. Marrinucci D, Bethel K, Bruce RH, et al. Case study of the morphologic variation of circulating tumor cells. Hum Pathol. 2007;38:514-519.
9. da Costa A, Oliveira JT, Gärtner F, Kohn B, Gruber AD, Klopfleisch R. Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood. Vet J. 2011;190:165-168.
10. Wiinberg B, Jensen AL, Johansson PI, Rozanski E, Tranholm M, Kristensen AT. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med. 2008;22:357-365.
11. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.
12. Wiinberg B, Jensen AL, Johansson PI, et al. Development of a model based scoring system for diagnosis of canine disseminated intravascular coagulation with independent assessment of sensitivity and specificity. Vet J. 2010;185:292-298.
13. Stockhaus C, Kohn B, Rudolph R, Brunnberg L, Giger U. Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma. J Small Anim Pract. 1999;40:326-331.
14. Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2001;86:828-833.
15. Maruyama H, Miura T, Sakai M, et al. The incidence of disseminated intravascular coagulation in dogs with malignant tumor. J Vet Med Sci. 2004;66:573-575.
16. Ludwig J, Kentos A, Crenier L, Dargent J-L, Capel P, Feremans W. Disseminated intravascular coagulation syndrome as a manifestation of breast adenocarcinoma metastasis [in French]. Rev Med Brux. 1997;18:385-388.
17. DelGiudice LA, White GA. The role of tissue factor and tissue factor pathway inhibitor in health and disease states. J Vet Emerg Crit Care. 2009;19:23-29.
18. Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009;22:129-136.
19. Fahl KN, Poon SA, Badani KK, Benson MC. Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma. Can Urol Assoc J. 2009;3:E61-E63.
20. Hill GR, Hickton CM, Brennan SO, Atkinson CH, Heaton DC. Acquired heparin-like anticoagulants: a second case in metastatic breast cancer carcinoma and literature review. Clin Lab Haematol. 1996;18:291-295.
21. Cathcart MC, Reynolds JV, O'Byrne KJ, Pidgeon GP. The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer. Biochim Biophys Acta. 2010;1805:153-166.
22. Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 2007;26:525-534.
23. Queiroga FL, Pires I, Lobo L, Lopes CS. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours. Res Vet Sci. 2010;88:441-445.
24. Kristensen AT, Wiinberg B, Jessen LR, Andreasen E, Jensen AL. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med. 2008;22:140-147.